Ambroxol - ALZFORUM
Apr 22, 2021 · Ambroxol is a mucolytic compound and the main ingredient of over-the-counter cough medicines sold in many countries. Syrup, tablet, and other forms are used at doses of …
Large Phase 2 Trial Starting Up in Genetic Parkinson’s Population
Jun 13, 2014 · Researchers in Canada recently evaluated the ability of the chaperone ambroxol to stimulate GBA activity in a small Phase 2 Parkinson’s study, and a similar trial of ambroxol is …
Early initiation of ambroxol treatment diminishes neurological ...
Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings. Eur J Paediatr Neurol. 2021 May;32:66-72. …
Ambroxol Hydrochloride Improves Motor Functions and Extends
Bouscary A, Quessada C, Mosbach A, Callizot N, Spedding M, Loeffler JP, Henriques A. Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of …
Identification and characterization of ambroxol as an enzyme ...
Maegawa GH, Tropak MB, Buttner JD, Rigat BA, Fuller M, Pandit D, Tang L, Kornhaber GJ, Hamuro Y, Clarke JT, Mahuran DJ. Identification and characterization of ambroxol as an …
Therapeutics | ALZFORUM
Nov 25, 2015 · AD Target / Therapy Types The two tables below organize the therapeutics within this database by therapy type and proposed target type. The number of therapeutics within …
Therapeutics Search | ALZFORUM
NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-1088 ABBV-552 ABBV-916 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24.060 …
Parkinson’s Treatments Go After Genetic Targets | ALZFORUM
Ambroxol is in Phase 2 PD trials in Canada and London, with a Phase 1 trial starting in Florida. Schapira led the London trial, AIM-PD, which enrolled 12 GBA carriers and 10 people with …
Therapeutics Search | ALZFORUM
155 Therapeutics View Results ResetSearch Results